N4 PHARMA PLC Logo

N4 PHARMA PLC

Develops a silica nanoparticle delivery system for nucleic acid-based treatments.

N4P | IL

Overview

Corporate Details

ISIN(s):
GB00BYW8QM32
LEI:
213800I841D2RKMFK955
Country:
United Kingdom
Address:
6TH FLOOR, EC3V 0HR LONDON

Description

N4 Pharma PLC is a specialist pharmaceutical company focused on the development of Nuvec®, its proprietary silica nanoparticle delivery system. This platform technology is designed to enhance the cellular delivery and potency of nucleic acid-based treatments, such as vaccines and cancer therapies. The company's primary focus is on applying Nuvec® to enable advanced therapies for oncology and infectious diseases. N4 Pharma's business model involves developing and out-licensing its technology to pharmaceutical and biotechnology partners to improve the performance of new and existing drugs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-23 08:00
Partnership with University of Strathclyde’s CMAC
English 19.6 KB
2025-09-22 08:00
N4 Pharma’s Nuvec® Targets Lung Cancer Cells
English 17.5 KB
2025-09-19 08:00
Notice of Results, Analyst & Investor Presentation
English 15.8 KB
2025-09-11 08:00
Investor Event and Presentation
English 13.9 KB
2025-07-30 14:55
Article on Nuvec®’s Potential in RNA Therapeutics
English 13.4 KB
2025-07-14 08:00
Investor Webinar
English 14.4 KB
2025-06-30 08:00
AGM Statement
English 25.8 KB
2025-06-06 08:00
Final Results, Annual Report and Notice of AGM
English 604.1 KB
2025-05-27 08:00
Establishment of New Senior Leadership Team
English 19.2 KB
2025-05-23 13:37
TR-1: Notification of major holdings
English 52.3 KB
2025-05-21 17:11
Holding(s) in Company
English 50.9 KB
2025-05-15 16:13
Change of Registered Address
English 12.2 KB
2025-05-09 09:24
Holding(s) in Company
English 50.7 KB
2025-04-29 17:25
Holding(s) in Company
English 52.1 KB
2025-04-29 12:05
Holding(s) in Company
English 52.3 KB

Automate Your Workflow. Get a real-time feed of all N4 PHARMA PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for N4 PHARMA PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for N4 PHARMA PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.